Champions Oncology, Inc. (CSBR)
NASDAQ: CSBR · Real-Time Price · USD
4.550
+0.250 (5.81%)
Nov 22, 2024, 4:00 PM EST - Market closed
Champions Oncology Employees
Champions Oncology had 210 employees as of April 30, 2024. The number of employees decreased by 20 or -8.70% compared to the previous year.
Employees
210
Change (1Y)
-20
Growth (1Y)
-8.70%
Revenue / Employee
$245,976
Profits / Employee
-$16,176
Market Cap
61.85M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
bluebird bio | 375 |
Atara Biotherapeutics | 225 |
Xtant Medical Holdings | 215 |
OptiNose | 132 |
Vicarious Surgical | 131 |
Mural Oncology | 117 |
Boundless Bio | 72 |
Immuneering | 68 |
CSBR News
- 5 weeks ago - Champions Oncology Announces Agreement with Weill Cornell Medicine - Accesswire
- 2 months ago - Champions Oncology, Inc. (CSBR) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Champions Oncology Reports Quarterly Revenue of $14.1 Million Adjusted EBITDA of $2.0 Million - Accesswire
- 2 months ago - Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 11, 2024 - Accesswire
- 4 months ago - Champions Oncology, Inc. (CSBR) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Champions Oncology Reports Quarterly Revenue of $14.0 Million - Accesswire
- 4 months ago - Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Thursday, July 18, 2024 - Accesswire
- 6 months ago - Champions Oncology and Medicines Discovery Catapult Forge Partnership to Accelerate Radiopharmaceutical Therapeutics Development - Accesswire